Will having a spin off company (NGIO) trading on the NASDQ be of any advantage for the parent company (GNBT) in its efforts to uplist to the NASDQ as well? Seems strange to me to have the parent company still trading on the OTC.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
